Literature DB >> 33467067

Molecular Aspects of Pruritus Pathogenesis in Psoriasis.

Kamila Jaworecka1, Joanna Muda-Urban1, Marian Rzepko2, Adam Reich1.   

Abstract

Psoriasis is a chronic, systemic inflammatory disease with a genetic background that involves almost 3% of the general population worldwide. Approximately, 70-90% of patients with psoriasis suffer from pruritus, an unpleasant sensation that provokes a desire to scratch. Despite the enormous progress in understanding the mechanisms that cause psoriasis, the pathogenesis of psoriasis-related pruritus still remains unclear. In order to improve patients' quality of life, development of more effective and safer antipruritic therapies is necessary. In turn to make it possible, better understanding of complexed and multifactorial pathogenesis of this symptom is needed. In this article we have systematized the current knowledge about pruritus origin in psoriasis.

Entities:  

Keywords:  itch; itching; palmoplantar pustulosis; pruritus; psoriasis

Mesh:

Substances:

Year:  2021        PMID: 33467067      PMCID: PMC7830783          DOI: 10.3390/ijms22020858

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  55 in total

1.  Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Authors:  Guanxiong Ding; Jie Fang; Shijun Tong; Lianxi Qu; Haowen Jiang; Qiang Ding; Jun Liu
Journal:  Prostate       Date:  2015-02-25       Impact factor: 4.104

2.  Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial.

Authors:  David M Pariser; Jerry Bagel; Mark Lebwohl; Gil Yosipovitch; Elaine Chien; Mary C Spellman
Journal:  J Am Acad Dermatol       Date:  2020-01-30       Impact factor: 11.527

3.  Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.

Authors:  Gil Yosipovitch; Sonja Ständer; Matthew B Kerby; James W Larrick; Andrew J Perlman; Edward F Schnipper; Xiaoming Zhang; Jean Y Tang; Thomas Luger; Martin Steinhoff
Journal:  J Am Acad Dermatol       Date:  2018-02-17       Impact factor: 11.527

Review 4.  Neuraxial opioid-induced itch and its pharmacological antagonism.

Authors:  Mei-Chuan Ko
Journal:  Handb Exp Pharmacol       Date:  2015

5.  The ion channel TRPA1 is required for chronic itch.

Authors:  Sarah R Wilson; Aislyn M Nelson; Lyn Batia; Takeshi Morita; Daniel Estandian; David M Owens; Ellen A Lumpkin; Diana M Bautista
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

6.  Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors.

Authors:  M Nakamura; M Toyoda; M Morohashi
Journal:  Br J Dermatol       Date:  2003-10       Impact factor: 9.302

7.  PRURITUS CHARACTERISTICS IN A LARGE ITALIAN COHORT OF PSORIATIC PATIENTS.

Authors:  Giovanni Damiani; Simone Cazzaniga; Rosalynn Rz Conic; Luigi Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-03-05       Impact factor: 6.166

Review 8.  Molecular and Cellular Mechanisms of Itch in Psoriasis.

Authors:  Eriko Komiya; Mitsutoshi Tominaga; Yayoi Kamata; Yasushi Suga; Kenji Takamori
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

9.  Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis.

Authors:  Norie Aizawa; Yozo Ishiuji; Mitsutoshi Tominaga; Sanae Sakata; Nobuaki Takahashi; Koichi Yanaba; Yoshinori Umezawa; Akihiko Asahina; Utako Kimura; Yasushi Suga; Kenji Takamori; Hidemi Nakagawa
Journal:  J Immunol Res       Date:  2019-01-21       Impact factor: 4.818

10.  Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis.

Authors:  Xenia Kodji; Kate L Arkless; Zizheng Kee; Simon J Cleary; Aisah A Aubdool; Elizabeth Evans; Paul Caton; Simon C Pitchford; Susan D Brain
Journal:  FASEB J       Date:  2018-09-11       Impact factor: 5.834

View more
  5 in total

Review 1.  Peripheral Mechanisms of Itch.

Authors:  Changxiong J Guo; Nathaniel S Grabinski; Qin Liu
Journal:  J Invest Dermatol       Date:  2021-11-24       Impact factor: 7.590

2.  CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway.

Authors:  Li Li; Xin Liu; Wenqiang Ge; Chao Chen; Yuqiong Huang; Zilin Jin; Muouyang Zhan; Xiaoru Duan; Xinxin Liu; Yi Kong; Jian Jiang; Xuemei Li; Xin Zeng; Fei Li; Shibin Xu; Man Li; Hongxiang Chen
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

Review 3.  Alcohol in Psoriasis-From Bench to Bedside.

Authors:  Zita Szentkereszty-Kovács; Krisztián Gáspár; Andrea Szegedi; Lajos Kemény; Dóra Kovács; Dániel Törőcsik
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

4.  Characteristics of Pruritus in Various Clinical Variants of Psoriasis: Results of the Multinational, Multicenter, Cross-Sectional Study.

Authors:  Kamila Jaworecka; Dominika Kwiatkowska; Luiza Marek; Funda Tamer; Aleksandra Stefaniak; Magdalena Szczegielniak; Joanna Chojnacka-Purpurowicz; Monika Matławska; Ayla Gulekon; Jacek C Szepietowski; Joanna Narbutt; Agnieszka Owczarczyk-Saczonek; Adam Reich
Journal:  Life (Basel)       Date:  2021-06-27

5.  Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.

Authors:  Fei Li; Dan Han; Bo Wang; Wentao Zhang; Yan Zhao; Jing Xu; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Journal:  Mediators Inflamm       Date:  2022-01-11       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.